Shenzhen Vapehome Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Vapehome Technology Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include APOC, AGAIN, and COILHOME. The owner is based in GUANGDONG.

RM. 1402,YUNHUA TIMES BLDG., HAOXIAN RD.

SHAJING ST., BAO'AN, SHENZHEN CITY

GUANGDONG 518100 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AGAIN
AGAIN
Registered 2023
APOC
APOC
Registered 2023
COILHOME
COILHOME
Registered 2020
AGAIN
AGAIN
Registered 2020

Trademark Classifications

Shenzhen Vapehome Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (4 filings)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Shenzhen Vapehome Technology Co., Ltd. have?

Shenzhen Vapehome Technology Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Shenzhen Vapehome Technology Co., Ltd. file in?

Shenzhen Vapehome Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 34 (Smokers Articles). Class 34 covers tobacco; smokers articles; matches.

What are Shenzhen Vapehome Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Vapehome Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as APOC, AGAIN, and COILHOME. These are among 4 currently registered trademarks in the portfolio.

What is Shenzhen Vapehome Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Vapehome Technology Co., Ltd. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.